ALMKT:EPA
Mauna Kea Technologies SA
€0.19
arrow_downward
-2.99%(-0.0058) 1D
4월 24일, 오후 3시 49분 59초 GMT+2 · EUR
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoALMKT의 주요 통계 생성 중...
시가
€0.20
고가
€0.20
저가
€0.19
시가총액
3683.66만
평균 거래량
177.11만
거래량
66.82만
52주 최고가
€0.23
52주 최저가
€0.07
EPS
-€0.14
유통 주식수
1.92억
직원 수
61
뉴스 기사
웹 소스 기반
Simply Wall Street
·
20분 전
Adobe’s AI CX Push With CX Enterprise And Firefly Raises Investor Questions
연합뉴스
·
34분 전
뉴욕증시, 미-이란 갈등 주목하며 혼조 출발
Investing.com 한국어
·
1시간 전
나스닥, Immersion에 상장 규정 준수 기한 연장 승인
프로필
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA에 관한 정보